CD4 binding site immunogens elicit heterologous anti–HIV-1 neutralizing antibodies in transgenic and wild-type animals
Science Immunology · 03.02.2023 · 8 (80)
DOI: 10.1126/sciimmunol.ade6364 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, erschienen am 03.02.2023. Verfasst von Harry B Gristick und 30 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA. Hauptthemen laut MEDLINE: Animals, Wild, HIV-1. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
Passive transfer of broadly neutralizing anti–HIV-1 antibodies (bNAbs) protects against infection, and therefore, eliciting bNAbs by vaccination is a major goal of HIV-1 vaccine efforts. bNAbs that target the CD4 binding site (CD4bs) on HIV-1 Env are among the most broadly active, but to date, responses elicited against this epitope in vaccinated animals have lacked potency and breadth. We hypothesized that CD4bs bNAbs resembling the antibody IOMA might be easier to elicit than other CD4bs antibodies that exhibit higher somatic mutation rates, a difficult-to-achieve mechanism to accommodate Env’s N276 gp120 N-glycan, and rare five-residue light chain complementarity-determining region 3. As an initial test of this idea, we developed IOMA germline–targeting Env immunogens and evaluated a sequential immunization regimen in transgenic mice expressing germline-reverted IOMA. These mice developed CD4bs epitope–specific responses with heterologous neutralization, and cloned antibodies overcame neutralization roadblocks, including accommodating the N276 gp120 glycan, with some neutralizing selected HIV-1 strains more potently than IOMA. The immunization regimen also elicited CD4bs-specific responses in mice containing polyclonal antibody repertoires as well as rabbits and rhesus macaques. Thus, germline targeting of IOMA-class antibody precursors represents a potential vaccine strategy to induce CD4bs bNAbs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA.
- Laboratory of Molecular Immunology, Rockefeller University, New York, NY 10065, USA.
- Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
- Department of Global Health, University of Washington, Seattle, WA 98195, USA.
- Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
ORCID-Profile: Harry B Gristick, Harald Hartweger, Maximilian Loewe, Jelle van Schooten, Victor Ramos, Thiago Y Oliveira, Yoshiaki Nishimura, Abigail Wall, Daniel Poston, Anna Gazumyan, Marcel Horning, Jennifer R Keeffe, Magnus A G Hoffmann, Zhi Yang, Kim-Marie A Dam, Leesa M Kakutani, Michael S Seaman, Mark Howarth, Andrew T McGuire, Leonidas Stamatatos, Malcolm A Martin, Anthony P West, Michel C Nussenzweig, Pamela J Bjorkman
Förderung
- NIAID NIH HHS
Zitieren
APA
Gristick, H. B., Hartweger, H., Loewe, M., van Schooten, J., Ramos, V., Oliveira, T. Y., Nishimura, Y., Koranda, N. S., Wall, A., Yao, K. H., Poston, D., Gazumyan, A., Wiatr, M., Horning, M., Keeffe, J. R., Hoffmann, M. A. G., Yang, Z., Abernathy, M. E., Dam, K. A., …, & Bjorkman, P. J. (2023). CD4 binding site immunogens elicit heterologous anti–HIV-1 neutralizing antibodies in transgenic and wild-type animals. Science Immunology, 8(80). https://doi.org/10.1126/sciimmunol.ade6364
Vancouver
Gristick HB, Hartweger H, Loewe M, van Schooten J, Ramos V, Oliveira TY, et al. CD4 binding site immunogens elicit heterologous anti–HIV-1 neutralizing antibodies in transgenic and wild-type animals. Science Immunology. 2023;8(80). doi:10.1126/sciimmunol.ade6364
BibTeX
@article{Gristick2023,
author = {Gristick, Harry B and Hartweger, Harald and Loewe, Maximilian and van Schooten, Jelle and Ramos, Victor and Oliveira, Thiago Y and Nishimura, Yoshiaki and Koranda, Nicholas S and Wall, Abigail and Yao, Kai-Hui and Poston, Daniel and Gazumyan, Anna and Wiatr, Marie and Horning, Marcel and Keeffe, Jennifer R and Hoffmann, Magnus A G and Yang, Zhi and Abernathy, Morgan E and Dam, Kim-Marie A and Gao, Han and Gnanapragasam, Priyanthi N P and Kakutani, Leesa M and Pavlovitch-Bedzyk, Ana Jimena and Seaman, Michael S and Howarth, Mark and McGuire, Andrew T and Stamatatos, Leonidas and Martin, Malcolm A and West, Anthony P and Nussenzweig, Michel C and Bjorkman, Pamela J},
title = {CD4 binding site immunogens elicit heterologous anti–HIV-1 neutralizing antibodies in transgenic and wild-type animals},
journal = {Science Immunology},
year = {2023},
volume = {8},
number = {80},
doi = {10.1126/sciimmunol.ade6364}
}
EUVIMED